Here are the 10-Q quarterly reports from Bio Green Med Sluti 6%PFD (BGMSP) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow BGMSP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BGMSP filings page.
Bio Green Med Solution, Inc. has transformed from a biopharmaceutical company into a Malaysia-based fire safety products and services business following the September 2025 acquisition of Fitters Sdn. Bhd. For the six months ended June 30, 2026, it generated $1.1 million of fire safety product revenue, with total assets of $7.9 million and cash of $3.8 million.
The company reported a net loss of $0.6 million for the six-month period, significantly lower than the $1.4 million loss a year earlier, and positive working capital of $5.3 million. General and administrative expenses declined sharply as one-time change-of-control and legacy biotech costs rolled off.
Management nonetheless concludes there is substantial doubt about the ability to continue as a going concern beyond the first quarter of 2027 without new capital or a strategic transaction. A Business Combination Agreement with Future NRG Sdn. Bhd. contemplates an exchange that would leave existing shareholders owning less than 1% of the combined company. In June 2026, the company raised $0.79 million in a private placement of 1.1 million common shares at $0.72 per share.
Bio Green Med Solution, Inc. reported its first full quarter focused on Malaysian fire-safety operations after exiting biopharma. For the three months ended March 31, 2026, revenue was $778,000, all from fire-safety products and services, with cost of sales of $635,000 and general and administrative expenses of $389,000, resulting in an operating loss of $246,000 and net loss of $197,000.
Cash and cash equivalents were $3.3 million and working capital was $4.8 million as of March 31, 2026, against an accumulated deficit of $454.6 million. Management expects existing cash to fund operations only into the fourth quarter of 2026 and explicitly states there is substantial doubt about the company’s ability to continue as a going concern without new financing or a strategic transaction.
The quarter reflects the consolidation of Fitters Sdn. Bhd., the Malaysian fire-safety subsidiary acquired in September 2025, and the absence of prior biopharma research and development, which has been fully discontinued. The company’s 6% Convertible Exchangeable Preferred Stock has been delisted from Nasdaq, although the common stock continues to trade under the ticker BGMS.